Industry Leaders Share Practical Solutions for Decarbonizing Carbon Goods in Cascale's Source of Good Podcast
PorAinvest
martes, 26 de agosto de 2025, 11:55 am ET1 min de lectura
ISPC--
iSpecimen Inc. (NASDAQ: ISPC), a leading online marketplace for human biospecimens, has successfully completed Milestone 1 of its digital transformation program, powered by Salestack Solutions. This milestone marks a significant advancement in modernizing the company's infrastructure, setting the stage for future innovation and operational efficiency [1].
The digital transformation program involves implementing Salestack's cloud-native platform to enhance the iSpecimen Marketplace® infrastructure. Key improvements include Infrastructure-as-Code (IaC), unified storage and workflows, and a future-ready foundation supporting multi-cloud deployment. These upgrades aim to provide automated security, improved reliability, and faster development cycles [1].
Robert Lim, CEO of iSpecimen, stated, "The successful completion of Milestone 1 is a major step forward in iSpecimen's mission to create the most efficient and secure marketplace in our industry. By leveraging Salestack's advanced platform, we are working to future-proof our systems, eliminate long-standing inefficiencies, and prepare for the next phases of integration, customization, and automation" [1].
The completion of Milestone 1 positions iSpecimen to advance to Milestone 2 (Integration), which will focus on connecting all parts of the company's business to the Salestack platform to create end-to-end efficiency across operations, customer engagement, and data management [1].
About iSpecimen
iSpecimen (NASDAQ: ISPC) offers an online marketplace for human biospecimens, connecting scientists in commercial and non-profit organizations with healthcare providers that have access to patients and specimens needed for medical discovery. Proprietary, cloud-based technology enables scientists to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers, and other healthcare organizations [1].
References
[1] https://www.stocktitan.net/news/ISPC/i-specimen-announces-completion-of-milestone-1-in-digital-tg0j3fmcimz7.html
Cascale's Source of Good podcast has completed Season 2, featuring 10 episodes showcasing industry leaders discussing practical solutions for decarbonizing carbon goods. The series highlights experts from manufacturers, brands, and service providers sharing their experiences and insights on renewable energy, supplier engagement, material innovation, and manufacturer practices. The podcast aims to accelerate supply chain transformation and promote collective climate action to reduce greenhouse gas emissions by 45% by 2030.
Title: iSpecimen Completes Milestone 1 in Digital Transformation ProgramiSpecimen Inc. (NASDAQ: ISPC), a leading online marketplace for human biospecimens, has successfully completed Milestone 1 of its digital transformation program, powered by Salestack Solutions. This milestone marks a significant advancement in modernizing the company's infrastructure, setting the stage for future innovation and operational efficiency [1].
The digital transformation program involves implementing Salestack's cloud-native platform to enhance the iSpecimen Marketplace® infrastructure. Key improvements include Infrastructure-as-Code (IaC), unified storage and workflows, and a future-ready foundation supporting multi-cloud deployment. These upgrades aim to provide automated security, improved reliability, and faster development cycles [1].
Robert Lim, CEO of iSpecimen, stated, "The successful completion of Milestone 1 is a major step forward in iSpecimen's mission to create the most efficient and secure marketplace in our industry. By leveraging Salestack's advanced platform, we are working to future-proof our systems, eliminate long-standing inefficiencies, and prepare for the next phases of integration, customization, and automation" [1].
The completion of Milestone 1 positions iSpecimen to advance to Milestone 2 (Integration), which will focus on connecting all parts of the company's business to the Salestack platform to create end-to-end efficiency across operations, customer engagement, and data management [1].
About iSpecimen
iSpecimen (NASDAQ: ISPC) offers an online marketplace for human biospecimens, connecting scientists in commercial and non-profit organizations with healthcare providers that have access to patients and specimens needed for medical discovery. Proprietary, cloud-based technology enables scientists to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers, and other healthcare organizations [1].
References
[1] https://www.stocktitan.net/news/ISPC/i-specimen-announces-completion-of-milestone-1-in-digital-tg0j3fmcimz7.html

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios